AGN : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash608179468590
Short Term Investments502979901706
ASSETS
Cash & Short Term Investments1,1101,1581,3691,296
Receivables - Net538463387246
Raw Materials51413012
Work in Progress37463125
Finished Goods17513710753
Inventories - Total26322516990
Prepaid Expenses80795558
Other Current Assets279199151136
CURRENT ASSETS - TOTAL2,2712,1242,1301,826
Land52383219
Buildings694614541476
Machinery & Equipment530457399318
Property, Plant and Equipment - Gross1,2751,109972812
Accumulated Depreciation(501)(423)(361)(318)
Property, Plant and Equipment - Net774686611494
Investments in Associated Companies6878
Other Investments110794942
Deferred Charges337118135
Other Tangible Assets38383946
Total Intangible Other Assets - Net3,5603,5732,912176
Other Assets - Total3,9773,9103,236357
TOTAL ASSETS6,7916,5795,7672,727
LIABILITIES
Accounts Payable17420914292
Short Term Debt & Current Portion of Long Term Debt440102690
Accrued Payroll13315512585
Income Taxes Payable4916540
Other Current Liabilities337296235177
CURRENT LIABILITIES - TOTAL6977166581,044
Long Term Debt1,6351,5901,60658
Provision for Risks and Charges1959010659
Deferred Income81838274
Deferred Taxes - Credit390449352--
Deferred Taxes - Debit346228267--
DEFERRED TAXES4422185(123)
Other Liabilities1271408649
TOTAL LIABILITIES2,7792,8392,6231,159
EQUITY
Non-Equity Reserves0000
Minority Interest2221
Preferred Stock0000
Common Stock3321
Capital Surplus2,5162,4502,360418
Other Appropriated Reserves(187)(66)(112)(4)
Retained Earnings1,8821,4241,0661,305
Unrealized Foreign Exchange Gain/Loss(10)30(16)(49)
Unrealized Gain/Loss on Marketable Securities(1)212
Treasury Stock(192)(104)(156)(107)
COMMON EQUITY4,0103,7393,1431,567
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY6,7916,5795,7672,727
SHARE INFORMATION
Common Shares Outstanding304306305266
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------608--
ASSETS
Cash & Short Term Investments1,6991,3881,0881,1101,013
Receivables - Net575579537538584
Inventories - Total230236255263270
Prepaid Expenses------80--
Other Current Assets318324346279266
CURRENT ASSETS - TOTAL2,8212,5272,2272,2712,133
Property, Plant and Equipment - Gross------1,275--
Accumulated Depreciation------(501)--
Property, Plant and Equipment - Net785781779774738
Investments in Associated Companies00060
Total Intangible Other Assets - Net3,3923,3883,4233,5603,527
Other Assets - Total3,6573,6313,6754,0873,795
TOTAL ASSETS7,2636,9386,6806,7916,666
LIABILITIES
Accounts Payable230187185174164
Short Term Debt & Current Portion of Long Term Debt1612144
Income Taxes Payable4166494
Other Current Liabilities506466419469507
CURRENT LIABILITIES - TOTAL756680611697678
Long Term Debt1,4551,4801,4901,6351,595
Deferred Taxes - Credit14252739076
Deferred Taxes - Debit------346--
DEFERRED TAXES1425274476
Other Liabilities471404395403320
TOTAL LIABILITIES2,6962,5892,5242,7792,669
EQUITY
Non-Equity Reserves00000
Minority Interest203222
Preferred Stock00000
Common Stock33333
Capital Surplus2,7112,6922,6782,5162,499
Retained Earnings2,1642,0121,8561,8821,756
Unrealized Foreign Exchange Gain/Loss------(10)--
Unrealized Gain/Loss on Marketable Securities------(1)--
Treasury Stock(177)(176)(158)(192)(211)
COMMON EQUITY4,5474,3464,1544,0103,994
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY7,2636,9386,6806,7916,666
SHARE INFORMATION
Common Shares Outstanding304304305304304
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted